- Home
- ATOS vs AVD Comparison
ATOS vs AVD Comparison
Compare ATOS & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- AVD
- Stock Information
- Founded
- ATOS 2009
- AVD 1969
- Country
- ATOS United States
- AVD United States
- Employees
- ATOS N/A
- AVD N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- AVD Agricultural Chemicals
- Sector
- ATOS Health Care
- AVD Industrials
- Exchange
- ATOS Nasdaq
- AVD Nasdaq
- Market Cap
- ATOS 107.2M
- AVD 104.4M
- IPO Year
- ATOS 2012
- AVD N/A
- Fundamental
- Price
- ATOS $0.82
- AVD $4.21
- Analyst Decision
- ATOS Strong Buy
- AVD Strong Buy
- Analyst Count
- ATOS 3
- AVD 1
- Target Price
- ATOS $6.17
- AVD $12.00
- AVG Volume (30 Days)
- ATOS 1.4M
- AVD 263.0K
- Earning Date
- ATOS 08-15-2025
- AVD 07-31-2025
- Dividend Yield
- ATOS N/A
- AVD N/A
- EPS Growth
- ATOS N/A
- AVD N/A
- EPS
- ATOS N/A
- AVD N/A
- Revenue
- ATOS N/A
- AVD $529,067,000.00
- Revenue This Year
- ATOS N/A
- AVD N/A
- Revenue Next Year
- ATOS N/A
- AVD $3.54
- P/E Ratio
- ATOS N/A
- AVD N/A
- Revenue Growth
- ATOS N/A
- AVD N/A
- 52 Week Low
- ATOS $0.55
- AVD $3.28
- 52 Week High
- ATOS $1.66
- AVD $9.62
- Technical
- Relative Strength Index (RSI)
- ATOS 44.93
- AVD 59.61
- Support Level
- ATOS $0.84
- AVD $3.29
- Resistance Level
- ATOS $0.98
- AVD $3.80
- Average True Range (ATR)
- ATOS 0.05
- AVD 0.26
- MACD
- ATOS -0.01
- AVD 0.06
- Stochastic Oscillator
- ATOS 7.65
- AVD 85.19
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.